A major new study, led by Queen Mary University of London and funded by the National Institute for Health and Care Research (NIHR) has been published ...

The global medical cyclotron market shows steady growth, expected to be valued at around US$246.8 million in 2026 and projected to reach US$405.4 million by 2033, with a CAGR of 5.4% during this ...

Organ-preserving treatment strategies are increasingly being explored for patients with rectal and esophageal cancers, with the shared goal of maintaining ...

The initiative has been designed to provide swift access to diagnostic testing for patients showing symptoms of the most ...

Research now shows that patients dream under anesthesia and report their dreams as uplifting, leading to more positive ...

In Perioperative Immunotherapy Advances: Insights from CheckMate-77T and KEYNOTE-671, our panel delves into the following ...

To bridge the gap between clinical exuberance and evidence-based practice, Todd Brown, MD, PhD, an endocrinologist and clinical investigator at Johns Hopkins University, sat down at the Conference on ...

On track for readout of RASolute 302, a Phase 3 trial of daraxonrasib in second line metastatic PDAC, in first half of 2026Continues to advance ...

BACKGROUND: Forecasts for the future prevalence of cardiovascular disease and stroke are crucial to guide efforts to improve health outcomes across the life course for women. METHODS: Using historical ...

Learn the quickest way to distinguish skeletal from dental malocclusion in dogs and cats from Emily Edstrom, DVM, DAVDC.

Updated ACVIM guidance prioritizes therapeutic diets and microbiome-directed therapy, identifying Visbiome Vet as the only probiotic currently backed by randomized clinical trial data for CIE.

A woman in her 40s presented with progressive cognitive decline, expressive language difficulty and episodic confusion. Her initial symptoms were misattributed to psychiatric illness, and later to ...